Cargando…

The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin

Acute kidney injury (AKI) in the setting of cirrhosis (hepatorenal syndrome [HRS]–AKI) is a severe and often fatal complication of end‐stage liver disease. The goals of treatment are to reverse renal failure and prolong survival in patients who are critically ill. However, interventions have limited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flamm, Steven L., Brown, Kimberly, Wadei, Hani M., Brown, Robert S., Kugelmas, Marcelo, Samaniego‐Picota, Milagros, Burra, Patrizia, Poordad, Fred, Saab, Sammy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Articles and Practice‐Based Recommendations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457138/ https://www.ncbi.nlm.nih.gov/pubmed/33848394 http://dx.doi.org/10.1002/lt.26072

Ejemplares similares

Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis
por: Kugelmas, Marcelo, et al.
Publicado: (2023)

Hepatorenal syndrome:Response to terlipressin and albumin and its determinants
por: Sarwar, Shahid, et al.
Publicado: (2016)

Good Enough? Terlipressin, Hepatorenal Syndrome, and the Usage of RRT
por: Belcher, Justin M.
Publicado: (2023)

Terlipressin effect on hepatorenal syndrome: Updated meta‐analysis of randomized controlled trials
por: Mohamed, Mohamed M G, et al.
Publicado: (2021)

An investigation of reconstituted terlipressin infusion stability for use in hepatorenal syndrome
por: Bui, Thi Ngoc Nhieu, et al.
Publicado: (2020)

The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome
por: Velez, Juan Carlos Q., et al.
Publicado: (2023)

Covid-19 (Sars-Cov-2 Infection) Information for Patients with Predialytic Chronic Kidney Disease
por: Delfino, Vinicius Daher Alvares, et al.
Publicado: (2020)

Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function
por: Huang, Xingyue, et al.
Publicado: (2023)

Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis
por: Wang, Haiqing, et al.
Publicado: (2018)

Terlipressin versus Norepinephrine in the Treatment of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis
por: Nassar Junior, Antonio Paulo, et al.
Publicado: (2014)

Recommendations from the Brazilian Society of Nephrology regarding the use of cloth face coverings, by chronic kidney patients in dialysis, during the new coronavirus pandemic (Covid-19)
por: de Abreu, Andrea Pio, et al.
Publicado: (2020)

Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome
por: Kim, Hae Rim, et al.
Publicado: (2013)

Terlipressin-Induced Peripheral Cyanosis in a Patient with Liver Cirrhosis and Hepatorenal Syndrome
por: Chiang, Chi-Wen, et al.
Publicado: (2019)

Terlipressin for the Prevention and Treatment of Renal Decline in Hepatorenal Syndrome: A Drug Profile
por: Ayyad, Ahlam, et al.
Publicado: (2023)

Technical note and clinical instructions for Acute Kidney Injury (AKI) in patients with Covid-19: Brazilian Society of Nephrology and Brazilian Association of Intensive Care Medicine
por: Suassuna, José Hermógenes Rocco, et al.
Publicado: (2020)

Fractional excretion of sodium in hepatorenal syndrome: Clinical and pathological correlation
por: Alsaad, Ali A, et al.
Publicado: (2016)

Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial
por: Karvellas, Constantine J., et al.
Publicado: (2023)

COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemic
por: Colares, Vinícius Sardão, et al.
Publicado: (2020)

Survival benefits of terlipressin and non-responder state in hepatorenal syndrome: A meta-analysis
por: Hiremath, Sharanabasayyaswamy B., et al.
Publicado: (2013)

Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?
por: Altun, Reskan, et al.
Publicado: (2015)

Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome
por: Moore, Kevin, et al.
Publicado: (2020)

Recommendations Of The Brazilian Society Of Nephrology Regarding Pediatric Patients On Renal Replacement Therapy During The Covid-19 Pandemic
por: Tavares, Marcelo de Sousa, et al.
Publicado: (2020)

Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome
por: Fisher, Benjamin A, et al.
Publicado: (2017)

Position statement from the Brazilian Society of Nephrology regarding chloroquine and hydroxychloroquine drug dose adjustment according to renal function
por: Moura-Neto, José A., et al.
Publicado: (2020)

Good practices recommendations from the Brazilian Society of Nephrology to Peritoneal Dialysis Services related to the new coronavirus (Covid-19) epidemic
por: Calice-Silva, Viviane, et al.
Publicado: (2020)

EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
por: Mankia, Kulveer, et al.
Publicado: (2021)

Good Practice Recommendations from the Brazilian Society of Nephrology to Dialysis Units Concerning the Pandemic of the New Coronavirus (Covid-19)
por: Moura-Neto, José A., et al.
Publicado: (2020)

Recommendations from the Brazilian Society of Nephrology for approaching Covid-19 Diagnostic Testing in Dialysis Units
por: Moura-Neto, José A., et al.
Publicado: (2020)

Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence
por: Bai, Zhaohui, et al.
Publicado: (2020)

Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies
por: Curry, Michael P., et al.
Publicado: (2023)

Pediatric acute liver failure: Reexamining key clinical features, current management, and research prospects
por: Ascher Bartlett, Johanna M., et al.
Publicado: (2022)

CAQ Corner: Acute liver failure management and liver transplantation
por: Pan, Jason J., et al.
Publicado: (2022)

Coagulopathy and hemostasis management in patients undergoing liver transplantation: Defining a dynamic spectrum across phases of care
por: Pillai, Anjana A., et al.
Publicado: (2022)

CAQ Corner: Surgical evaluation for liver transplantation
por: Misra, Asish C., et al.
Publicado: (2022)

Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute‐on‐chronic liver failure
por: Wong, Florence, et al.
Publicado: (2022)

Successful simultaneous pancreas and kidney transplant in a patient post–COVID-19 infection
por: Singh, Neeraj, et al.
Publicado: (2020)

Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Heidelberg Consensus Recommendations on Trustmarks
Publicado: (2000)

Treatment recommendations for psoriatic arthritis
por: Ritchlin, C T, et al.
Publicado: (2009)

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
por: Gerlag, Danielle M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gj7r3c3dgbnv0fe9cqev4fck9r